News

SA biotech buys Birmingham company

CytoBioscience CEO James Garvin said the acquisition of BioDtech is a big win for his San Antonio-based ...

SA biotech CEO: Company on the verge of taking cancer-detection product to market

Seno Medical Instruments Inc. CEO Tom Umbel said the company is picking up momentum. GABE HERNANDEZ | ...

Events

BioMed SA Annual Breakfast Meeting

When: 7:30-9:30 AM Tuesday, December 18, 2018 Where: Omni Hotel, 9821 Colonnade Blvd. Join ...
News
Texas Biomedical Research Institute names new CEO
February 4, 2017

Larry Schlesinger was named president and CEO of Texas Biomedical Research Institute. Courtesy Texas Biomed.

By Brittney Martin, San Antonio Express-News

The Texas Biomedical Research Institute in San Antonio chose Dr. Larry Schlesinger, a tuberculosis expert at Ohio State University, as its new president and CEO on Friday.

Schlesinger is currently chair of the Department of Microbial Infection and Immunity and the director of the Center for Microbial Interface Biology at Ohio State University. In addition to leading the institute, Schlesinger will bring with him his ongoing research on immunities to infectious diseases.

"The institute has a reputation for dealing with some of the most difficult medical issues in the world, and I look forward to what we can all accomplish together in the future," Schlesinger said.

Dr. James O. Rubin, chair of the board of trustees, said Schlesinger stood out after an extensive search. He has more than 30 years of experience in the field.

"He is an eminent researcher in his own right and will bring with him a team of experts and funding which will greatly grow our efforts to combat tuberculosis," Rubin said.

Schlesinger will start May 31. Texas Biomedical Research Institute is an independent research institution committed to furthering advancements in global health. Its researchers contribute to the fights against AIDS, malaria, hepatitis and other infectious diseases.

 

Stay informed. Subscribe to BioMed SA news alerts.